These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4612924)

  • 41. Escherichia coli K antigen.
    Kaijser B; Vahlne G
    Zentralbl Bakteriol Orig A; 1979 Apr; 243(2-3):271-88. PubMed ID: 377857
    [No Abstract]   [Full Text] [Related]  

  • 42. O, K, H and fimbrial antigens in Escherichia coli serotypes associated with pyelonephritis and cystitis.
    Orskov I; Orskov F; Birch-Andersen A; Kanamori M; Svanborg-Edén C
    Scand J Infect Dis Suppl; 1982; 33():18-25. PubMed ID: 6127800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimentally induced chronic pyelonephritis using bacterial antigen and its prevention with immunosuppression.
    Strong DW; Lawson RK; Hodges CV
    Invest Urol; 1974 May; 11(6):479-85. PubMed ID: 4597433
    [No Abstract]   [Full Text] [Related]  

  • 44. [The pathogenesis of pyelonephritis].
    Golokolosov AS
    Pediatriia; 1972 Oct; 51(10):78-82. PubMed ID: 4581200
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of suppressor cells in experimental pyelonephritis.
    Smith JW
    J Infect Dis; 1980 Aug; 142(2):199-204. PubMed ID: 6447737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of antibody-coated bacteria in urinary sediment in experimental pyelonephritis.
    Smith JW; Jones SR; Kaijser B
    J Infect Dis; 1977 Apr; 135(4):577-81. PubMed ID: 323377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preliminary results of the vaccine treatment of chronic pyelonephritis in animal experiments].
    Straube E; Broschewitz U; Schill H; Naumann G
    Z Urol Nephrol; 1984 Jul; 77(7):401-5. PubMed ID: 6385543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
    Straube E; Naumann G; Broschewitz U
    Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental chronic pyelonephritis: demonstration of the bacterial antigen using fluorescent antibody technic].
    Bégué P
    Nouv Presse Med; 1973 Nov; 2(41):2747-8. PubMed ID: 4589878
    [No Abstract]   [Full Text] [Related]  

  • 50. Virulence of Escherichia coli strains in relation to their hemolysin formation, mannose-resistant hemagglutination, hydroxamate production, K 1-antigen and the plasmid profile in patients with chronic pyelonephritis.
    Fünfstück R; Tschäpe H; Stein G; Vollandt R; Schneider S
    Clin Nephrol; 1989 Oct; 32(4):178-84. PubMed ID: 2680194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Serologic diagnosis of pyelonephritis in children based on passive hemagglutination tests using polyvalent and specific E. coli antigens].
    Zaremba M; Lachmajer M
    Pediatr Pol; 1973 May; 48(5):589-94. PubMed ID: 4575820
    [No Abstract]   [Full Text] [Related]  

  • 52. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental pyelonephritis. Route of infection, course and immunological aspects.
    Tuan H; Hagemann I; Briedigkeit H; Dutz W
    Int Urol Nephrol; 1972; 4(3):285-95. PubMed ID: 4592133
    [No Abstract]   [Full Text] [Related]  

  • 54. A fluorescent antibody method to distinguish vegetative cells from spheroplasts of an Escherichia coli strain.
    Demonty J
    Antonie Van Leeuwenhoek; 1969; 35(4):409-17. PubMed ID: 4989533
    [No Abstract]   [Full Text] [Related]  

  • 55. T lymphocyte responses to antigens of gram-negative bacteria in pyelonephritis.
    Wilz SW; Kurnick JT; Pandolfi F; Rubin RH; Warren HS; Goldstein R; Kersten CM; McCluskey RT
    Clin Immunol Immunopathol; 1993 Oct; 69(1):36-42. PubMed ID: 8403542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New findings in the pathogenesis of pyelonephritis].
    Gruev I
    Vutr Boles; 1984; 23(5):17-20. PubMed ID: 6395491
    [No Abstract]   [Full Text] [Related]  

  • 57. Antibodies to Escherichia coli K and O antigens in protection against acute pyelonephritis.
    Kaijser B; Larsson P; Nimmich W; Söderström T
    Prog Allergy; 1983; 33():275-88. PubMed ID: 6187016
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies of secretory antibodies to E. coli in human urine compared to the serum antibody content.
    Hanson LA; Ahlstedt S; Carlsson B; Jodal U; Lindberg U; Sohl A
    Adv Exp Med Biol; 1974; 45(0):399-408. PubMed ID: 4607111
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of antibodies against autologous E. coli strains in children with pyelonephritis].
    Zernov NG; Tebloeva LT; Pugacheva VI; Andreeva ZM; Ershova EB
    Urol Nefrol (Mosk); 1976; (3):16-8. PubMed ID: 788284
    [No Abstract]   [Full Text] [Related]  

  • 60. Fluorescent antibody as a method for the detection of fecal pollution: Escherichia coli as indicator organisms.
    Abshire RL; Guthrie RK
    Can J Microbiol; 1973 Feb; 19(2):201-6. PubMed ID: 4572376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.